Simultaneous Targeting of RAF, MEK, and ERK Limits Drug Resistance

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2017-142
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Targeting the Ras/Raf/Mek/Erk Pathway in Hepatocellular Carcinoma (Review)

Oncology Letters
Cancer ResearchOncology
2017English

Targeting Alterations in the RAF–MEK Pathway

Cancer Discovery
Oncology
2019English

Prohibitins Role in Cellular Survival Through Ras-Raf-Mek-Erk Pathway

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2014English

MicroRNA‑98 Suppresses Cell Growth and Invasion of Retinoblastoma via Targeting the IGF1R/k‑Ras/Raf/MEK/ERK Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2019English

MEK1 Mutations Confer Resistance to MEK and B-Raf Inhibition

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Modulation of the Akt/Ras/Raf/Mek/Erk Pathway by A3 Adenosine Receptor

Purinergic Signalling
Molecular NeuroscienceCell BiologyMolecular BiologyCellular
2006English

Molecular Signaling in Multiple Myeloma: Association of RAS/RAF Mutations and MEK/ERK Pathway Activation

Oncogenesis
Cancer ResearchMolecular Biology
2017English

Astragaloside IV Attenuates Glutamate-Induced Neurotoxicity in PC12 Cells Through Raf-Mek-Erk Pathway

PLoS ONE
Multidisciplinary
2015English

Norcantharidin Induces Growth Inhibition and Apoptosis of Glioma Cells by Blocking the Raf/Mek/Erk Pathway

World Journal of Surgical Oncology
SurgeryOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy